Factors determining disease duration in Alzheimer's disease: A postmortem study of 103 cases using the Kaplan-Meier estimator and Cox regression

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Armstrong, R A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; AUTOPSY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; NEUROFIBRILLARY TANGLE; ONSET AGE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; AUTOPSY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID; PRESENILIN-1; PROPORTIONAL HAZARDS MODELS;

EID: 84893772142     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/623487     Document Type: Article

References (57)

1. Bowen J. D., Malter A. D., Sheppard L., Kukull W. A., McCormick W. C., Teri L., Larson E. B., Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 1996 47 2 433 439 2-s2.0-0029787185 (Pubitemid 26324039)
2. Ueki A., Shinjo H., Shimode H., Nakajima T., Morita Y., Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study. International Journal of Geriatric Psychiatry 2001 16 8 810 815 2-s2.0-0034846121 10.1002/gps.419 (Pubitemid 32834119)
3. Brodaty H., Seeher K., Gibson L., Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. International Psychogeriatrics 2012 24 1034 11045
4. Armstrong R. A., Myers D., Principal components analysis of Alzheimer's disease based on neuropathological data: a study of 79 patients. Neuroscience Research Communications 1992 11 1 1 9 2-s2.0-0026753914
5. Armstrong R. A., Wood L., The identification of pathological subtypes of Alzheimer's disease using cluster analysis. Acta Neuropathologica 1994 88 1 60 66 2-s2.0-0028358134 10.1007/BF00294360 (Pubitemid 24211021)
6. Armstrong R. A., Nochlin D., Bird T. D., Neuropathological heterogeneity in Alzheimer's disease: a study of 80 cases using principal components analysis. Neuropathology 2000 20 1 31 37 2-s2.0-0034111406 10.1046/j.1440-1789.2000. 00284.x (Pubitemid 30312574)
7. Chui H. C., Teng E. L., Henderson V. W., Moy A. C., Clinical subtypes of dementia of the Alzheimer type. Neurology 1985 35 11 1544 1550 2-s2.0-0022204961 (Pubitemid 16248660)
8. Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M., Early-onset Alzheimer's disease caused by mutations at codon 717 of the β -amyloid precursor protein gene. Nature 1991 353 6347 844 846 2-s2.0-0026075602 10.1038/353844a0 (Pubitemid 21912637)
9. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Hardy J., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991 349 6311 704 706 2-s2.0-0026088977 10.1038/349704a0 (Pubitemid 21912142)
10. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., St George-Hyslop P. H., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995 375 6534 754 760 2-s2.0-0029004341
11. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C.-E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y.-H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E., Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995 269 5226 973 977 2-s2.0-0029087026
12. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L.-M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D., Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1993 90 17 8098 8102 2-s2.0-12044254746 (Pubitemid 23260862)
13. Boller F., Reisberg B., Alzheimer's disease and Parkinson's disease: clinical and pathological associations. Alzheimer's Disease. The Standard Reference 1983 London, UK MacMillan 295 302
14. Dickson D. W., Ruan D., Crystal H., Mark M. H., Davies P., Kress Y., Yen S.-H., Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991 41 9 1402 1409 2-s2.0-0025943418
15. Brun A., Englund E., A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Annals of Neurology 1986 19 3 253 262 2-s2.0-0022572209 (Pubitemid 16111074)
16. Komarova N. L., Thalhauser C. J., High degree of heterogeneity in Alzheimer's disease progression patterns. PLOS Comparative Biology 2011 7 e1002251
17. Thalhauser C. J., Komarova N. L., Alzheimer's disease: rapid and slow progression. Journal of the Royal Society Interface 2012 9 66 119 126 2-s2.0-84855421397 10.1098/rsif.2011.0134
18. Schmidt C., Haik S., Satoh K., Rabano A., Martinez-Martin P., Roeber S., Rapidly progressive Alzheimer's disease: a multicenter update. Journal of Alzheimer's Disease 2010 30 751 756
19. Nitrini R., Caramelli P., Herrera E. Jr., de Castro I., Bahia V. S., Anghinah R., Caixeta L. F., Radanovic M., Charchat-Fichman H., Porto C. S., Carthery M. T., Hartmann A. P. J., Huang N., Smid J., Lima E. P., Takahashi D. Y., Takada L. T., Mortality from dementia in a community-dwelling Brazilian population. International Journal of Geriatric Psychiatry 2005 20 3 247 253 2-s2.0-20144370553 10.1002/gps.1274 (Pubitemid 40426025)
20. Hodges J. R., Mitchell J., Dawson K., Spillantini M. G., Xuereb J. H., McMonagle P., Nestor P. J., Patterson K., Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 2010 133 1 300 306 2-s2.0-74249101783 10.1093/brain/awp248
21. Zekry D., Herrmann F. R., Graf C. E., Giannelli S., Michel J.-P., Gold G., Krause K.-H., High levels of comorbidity and disability cancel out the dementia effect in predictions of long-term mortality after discharge in the very old. Dementia and Geriatric Cognitive Disorders 2011 32 2 103 110 2-s2.0-80054866719 10.1159/000326950
22. Tierney M. C., Fisher R. H., Lewis A. J., Zorzitto M. L., Snow W. G., Reid D. W., Nieuwstraten P., The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988 38 3 359 364 2-s2.0-0023833603 (Pubitemid 18083667)
23. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L., The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991 41 4 479 486 2-s2.0-0025908356
24. Ball M., Braak H., Coleman P., Dickson D., Duyckaerts C., Gambetti P., Hansen L., Hyman B., Jellinger K., Markesbery W., Perl D., Powers J., Price J., Trojanowski J. Q., Wisniewski H., Phelps C., Khachaturian Z., Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiology of Aging 1997 18 4 S1 S2 2-s2.0-0030681215 10.1016/S0197-4580(97) 00057-2 (Pubitemid 27454689)
25. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991 82 4 239 259 2-s2.0-0025863618
26. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., del Tredici K., Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica 2006 112 4 389 404 2-s2.0-33749150163 10.1007/s00401-006-0127-z (Pubitemid 44469160)
27. Khatchaturian Z. S., Diagnosis of Alzheimer's disease. Archives of Neurology 1985 42 1097 1005
28. Armstrong R. A., Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology 2003 42 6 521 529 2-s2.0-0037495279 10.1046/j.1365-2559.2003. 01601.x (Pubitemid 36688145)
29. Doody R., Pavlik V., Massman P., Kenan M., Yeh S., Powell S., Cooke N., Dyer C., Demirovic J., Waring S., Chan W., Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dementia and Geriatric Cognitive Disorders 2005 20 2-3 198 208 2-s2.0-23944435182 10.1159/000087300 (Pubitemid 41191638)
30. Feldman H. H., Pirttila T., Dartigues J. F., Everitt B., van Baelen B., Brashear H. R., Berlin J. A., Battisti W. P., Kavanagh S., Analyses of mortality risk in patients with dementia treated with galantamine. Acta Neurologica Scandinavica 2009 119 1 22 31 2-s2.0-58149083904 10.1111/j.1600-0404.2008.01047. x
31. Musicco M., Salamone G., Caltagirone C., Cravello L., Fadda L., Lupo F., Mosti S., Perri R., Palmer K., Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2010 30 3 219 228 2-s2.0-77956464304 10.1159/000319533
32. Hui J. S., Wilson R. S., Bennett D. A., Bienias J. L., Gilley D. W., Evans D. A., Rate of cognitive decline and mortality in Alzheimer's disease. Neurology 2003 61 10 1356 1361 2-s2.0-0344442703 (Pubitemid 37463370)
33. Bruandet A., Richard F., Bombois S., Maurage C. A., Masse I., Amouyel P., Pasquier F., Cognitive decline and survival in Alzheimer's disease according to education level. Dementia and Geriatric Cognitive Disorders 2008 25 1 74 80 2-s2.0-37349001763 10.1159/000111693 (Pubitemid 350308390)
34. Gambassi G., Lapane K. L., Landi F., Sgadari A., Mor V., Bernabei R., Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Neurology 1999 53 3 508 516 2-s2.0-0033546634 (Pubitemid 29382043)
35. Claus J. J., van Gool W. A., Teuniss S., Walstra G. J. M., Kwa V. I. H., Hijdra A., Verbeeten B. Jr., Koelman J. H. T. M., Bour L. J., Ongerboer De Visser B. W., Predicting survival in patients with early Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 1998 9 5 284 293 2-s2.0-7344266885 10.1159/000017073 (Pubitemid 28377229)
36. Shepherd C. E., Gregory G. C., Vickers J. C., Brooks W. S., Kwok J. B. J., Schofield P. R., Kril J. J., Halliday G. M., Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques. Neurobiology of Disease 2004 15 1 115 119 2-s2.0-1642456618 10.1016/j.nbd.2003.10.008 (Pubitemid 38134386)
37. Haupt M., Kurz A., Pollmann S., Romero B., Alzheimer's disease: identical phenotype of familial and non-familial cases. Journal of Neurology 1992 239 5 248 250 2-s2.0-0026572346
38. Nochlin D., van Belle G., Bird D., Sumi S. M., Comparison of the severity of neuropathologic changes in familial add sporadic Alzheimer's disease. Alzheimer Disease and Associated Disorders 1993 7 4 212 222 2-s2.0-0027438964 (Pubitemid 23351192)
39. Armstrong R. A., Spatial patterns of β -amyloid (A β) deposits in familial and sporadic Alzheimer's disease. Folia Neuropathologica 2011 49 3 153 161 2-s2.0-80053525105
40. Zhou B., Zhao Q. H., Teramukai S., Ding D., Guo Q. H., Fukushima M., Hong Z., Executive function predicts survival in Alzheimer disease: a study in Shanghai. Journal of Alzheimer's Disease 2010 22 2 673 682 2-s2.0-78650828914 10.3233/JAD-2010-100318
41. van Oijen M., de Jong F. J., Witteman J. C. M., Hofman A., Koudstaal P. J., Breteler M. M. B., Atherosclerosis and risk for dementia. Annals of Neurology 2007 61 5 403 410 2-s2.0-34249936328 10.1002/ana.21073 (Pubitemid 46878768)
42. Weiner M. F., Risser R. C., Effect of educational attainment on survival in Alzheimer's disease. Alzheimer's Reports 1998 1 6 369 374 2-s2.0-33746676271 (Pubitemid 128733363)
43. Coppus A. M. W., Evenhuis H. M., Verberne G.-J., Visser F. E., Oostra B. A., Eikelenboom P., van Gool W. A., Janssens A. C. J. W., van Duijn C. M., Survival in elderly persons with down syndrome. Journal of the American Geriatrics Society 2008 56 12 2311 2316 2-s2.0-57149130551 10.1111/j.1532-5415. 2008.01999.x
44. Mann D. M. A., Esiri M. M., The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Downs' syndrome. Journal of the Neurological Sciences 1989 89 2-3 169 179 2-s2.0-0024503377 (Pubitemid 19052948)
45. Mann D. M. A., Younis N., Jones D., Stoddart R. W., The time course of the pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of o β /A4. Neurodegeneration 1992 1 201 215
46. Motte J., Williams R. S., Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathologica 1989 77 5 535 546 2-s2.0-0024602541 (Pubitemid 19095419)
47. Oyama F., Shimada H., Oyama R., Ihara Y., Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population. Molecular Brain Research 1995 29 1 92 98 2-s2.0-0028946291 10.1016/0169-328X(94) 00233-5
48. Gomez-Isla T., West H. L., Rebeck G. W., Harr S. D., Growdon J. H., Locascio J. J., Perls T. T., Lipsitz L. A., Hyman B. T., Clinical and pathological correlates of apolipoprotein ε 4 in Alzheimer's disease. Annals of Neurology 1996 39 1 62 70 2-s2.0-0030050286
49. Tilvis R. S., Strandberg T. E., Juva K., Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. Journal of the American Geriatrics Society 1998 46 6 712 715 2-s2.0-0031744797 (Pubitemid 28262346)
50. Staff R. T., Murray A. D., Ahearn T., Salarirad S., Mowat D., Starr J. M., Deary I. J., Lemmon H., Whalley L. J., Brain volume and survival from age 78 to 85: the contribution of alzheimer-type magnetic resonance imaging findings. Journal of the American Geriatrics Society 2010 58 4 688 695 2-s2.0-77950430998 10.1111/j.1532-5415.2010.02765.x
51. Pearson R. C. A., Esiri M. M., Hiorns R. W., Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1985 82 13 4531 4534 2-s2.0-0345512210 (Pubitemid 15233154)
52. Armstrong R. A., Myers D., Smith C. U. M., Alzheimer's disease: size class frequency distribution of senile plaques: do they indicate when a brain tissue was affected? Neuroscience Letters 1991 127 2 223 226 2-s2.0-0025879025 10.1016/0304-3940(91)90799-Y
53. de Lacoste M.-C., White C. L. III, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiology of Aging 1993 14 1 1 16 2-s2.0-0027511389 10.1016/0197-4580(93)90015-4 (Pubitemid 23043049)
54. Armstrong R. A., Slaven A., Does the neurodegeneration of Alzheimer's disease spread between visual cortical regions B17 and B18 via the feedforward or feedback short cortico-cortical projections? Neurodegeneration 1994 3 191 196
55. Armstrong R. A., Cairns N. J., Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders. Journal of Neural Transmission 2012 119 1551 1560
56. Goedert M., Clavaguera F., Tolnay M., The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends in Neurosciences 2010 33 7 317 325 2-s2.0-77954385676 10.1016/j.tins.2010.04.003
57. Steiner J. A., Angot E., Brundin P., A deadly spread: cellular mechanisms of α -synuclein transfer. Cell Death and Differentiation 2011 18 9 1425 1433 2-s2.0-80051707299 10.1038/cdd.2011.53